Dose-Ranging and Cumulative Dose Studies of Albuterol Sulfate MDI in Co-Suspension Delivery™ Technology (AS MDI; PT007) in Patients with Asthma: the ASPEN and ANTORA Trials

BACKGROUND AND OBJECTIVES: Co-suspension Delivery™ Technology has been developed for the administration of albuterol sulfate pressurised inhalation suspension via metered-dose inhaler (AS MDI, PT007). We assessed the efficacy and safety of AS MDI versus Proventil(®) in order to determine the optimal...

Descripción completa

Detalles Bibliográficos
Autores principales: Cappelletti, Christy, Maes, Andrea, Rossman, Kimberly, Gillen, Michael, LaForce, Craig, Kerwin, Edward M., Reisner, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195775/
https://www.ncbi.nlm.nih.gov/pubmed/34089147
http://dx.doi.org/10.1007/s40261-021-01040-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195775/
https://www.ncbi.nlm.nih.gov/pubmed/34089147
http://dx.doi.org/10.1007/s40261-021-01040-7

Ejemplares similares